Intercept Pharmaceuticals (ICPT) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free ICPT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline89bio gains 47% on topline data for NASH candidatemsn.com - March 21 at 6:15 PMIntercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBCglobenewswire.com - February 29 at 8:30 AMIntercept Announces New Phase 2 Data Showing Significant Impact of OCA-Bezafibrate Combination on Normalization of Multiple Key Biomarkers of PBC-Induced Liver Damage at AASLD The Liver Meeting® 2023finance.yahoo.com - November 13 at 10:04 AMIntercept Announces New Findings from Long-term Extension of Landmark POISE Trial in PBC Showing Importance of Biomarkers Beyond ALP at AASLD The Liver Meeting® 2023finance.yahoo.com - November 10 at 8:38 AMmarketbeat.com - November 8 at 6:11 AMAlfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc.finance.yahoo.com - November 8 at 3:49 AMIntercept Pharmaceuticals (ICPT) Price Target Increased by 6.63% to 19.38msn.com - November 2 at 10:57 PMWill Intercept Pharmaceuticals (ICPT) Report Negative Q3 Earnings? What You Should Knowfinance.yahoo.com - October 31 at 1:27 PMStocks to Sell: 7 Overbought Companies You Ought to Dump Right Nowfinance.yahoo.com - October 27 at 2:49 AMIntercept Pharmaceuticals (NASDAQ:ICPT) shareholders have endured a 83% loss from investing in the stock five years agofinance.yahoo.com - October 11 at 12:51 PMIntercept Pharmaceuticals (ICPT) Price Target Increased by 21.49% to 18.17msn.com - October 5 at 10:40 PMIntercept Pharma unlikely to see rival offers, other roadblocks, analysts saymsn.com - September 28 at 10:48 PMCanaccord Genuity Downgrades Intercept Pharmaceuticals (ICPT)msn.com - September 28 at 10:48 PMRoyal Bank of Canada Increases Intercept Pharmaceuticals (NASDAQ:ICPT) Price Target to $19.00marketbeat.com - September 27 at 9:40 AMIntercept Pharma Acquisition by Alfasigma: A Strategic Move and Fair Value Assessmentmarkets.businessinsider.com - September 27 at 5:01 AMIntercept Pharmaceuticals stock soars on Alfasigma acquisition dealproactiveinvestors.com - September 27 at 5:01 AMCanaccord cuts Intercept to hold, calls Alfasigma deal "best possible outcome"msn.com - September 26 at 9:08 PMShareholder Alert: Ademi LLP investigates whether Intercept Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Alfasigmabenzinga.com - September 26 at 4:07 PMIntercept Pharmaceuticals: Alfasigma Pays Premium For M&A Deal That Suits All Partiesseekingalpha.com - September 26 at 3:35 PMWhy Is Intercept Pharmaceuticals (ICPT) Stock Up 75% Today?investorplace.com - September 26 at 3:10 PMIntercept Pharma Shares Surge Toward Alfasigma Acquisition Pricemarketwatch.com - September 26 at 11:07 AMIntercept Pharmaceuticals’ stock set to soar after Alfasigma buyout deal for an 82% premiummsn.com - September 26 at 11:07 AMItaly's Alfasigma to buy drugmaker Intercept for nearly $800 mlnreuters.com - September 26 at 11:07 AMAlfasigma To Acquire Intercept Pharma Fo $19 Per Share In Cashmarkets.businessinsider.com - September 26 at 11:07 AMWhy Is Rare Liver Disease Focused Intercept Pharmaceuticals Stock Trading Higher Today?markets.businessinsider.com - September 26 at 11:07 AMAlfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseasesfinance.yahoo.com - September 26 at 11:07 AMUPDATE 2-Italy's Alfasigma to buy US liver disease drugmaker Intercept for nearly $800 mlnfinance.yahoo.com - September 26 at 11:07 AMmarketbeat.com - September 26 at 7:59 AMFY2025 EPS Estimates for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Lifted by Zacks Researchmarketbeat.com - September 20 at 6:38 AMIntercept Pharma (ICPT) Receives a Hold from RBC Capitalmarkets.businessinsider.com - September 9 at 12:09 AMWhy CymaBay Therapeutics Stock Is Jumping Todayfinance.yahoo.com - September 8 at 2:08 PMWhy Is Fate Therapeutics (FATE) Down 23.5% Since Last Earnings Report?finance.yahoo.com - September 7 at 3:39 PMCredit Suisse AG Has $1.71 Million Stock Holdings in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)marketbeat.com - September 6 at 4:24 AMExodusPoint Capital Management LP Has $1.04 Million Stock Holdings in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)marketbeat.com - September 5 at 5:27 AMWhy Is Intercept (ICPT) Up 0.6% Since Last Earnings Report?finance.yahoo.com - September 1 at 5:23 PMLeerink Partnrs Equities Analysts Lift Earnings Estimates for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)marketbeat.com - August 28 at 2:18 AMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Shares Acquired by Pictet Asset Management SAmarketbeat.com - August 23 at 6:10 AMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Shares Bought by Mirae Asset Global Investments Co. Ltd.marketbeat.com - August 22 at 4:21 AMQ3 2023 Earnings Forecast for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Issued By Zacks Researchmarketbeat.com - August 21 at 1:52 AMZacks Research Weighs in on Intercept Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:ICPT)marketbeat.com - August 18 at 8:18 AMIntercept Pharmaceuticals (NASDAQ:ICPT) Downgraded to Hold at StockNews.commarketbeat.com - August 11 at 1:10 AMB. Riley Weighs in on Intercept Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:ICPT)marketbeat.com - August 7 at 8:28 AMCanaccord Genuity Maintains Intercept Pharmaceuticals (ICPT) Buy Recommendationmsn.com - August 4 at 2:38 AMIntercept: Narrowed Market, Concentrated Strategy (Rating Upgrade)seekingalpha.com - August 3 at 6:45 PMIntercept Pharmaceuticals, Inc.: Intercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updatesfinanznachrichten.de - August 2 at 1:17 PMIntercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updatesfinance.yahoo.com - August 2 at 1:17 PMIntercept (ICPT) Q2 Earnings Top Estimates, Revenues Up Y/Yfinance.yahoo.com - August 2 at 1:16 PMIntercept Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentationseekingalpha.com - August 2 at 9:36 AMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Receives Average Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - August 2 at 2:44 AMArizona State Retirement System Makes New Investment in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)marketbeat.com - August 1 at 6:15 AM Get Intercept Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ICPT and its competitors with MarketBeat's FREE daily newsletter. Email Address The Hard Truth About Investing For Retirement (Ad)Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading. Click To Access This Powerful Training Right Now! ICPT Media Mentions By Week ICPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ICPT News Sentiment▼0.300.33▲Average Medical News Sentiment ICPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ICPT Articles This Week▼02▲ICPT Articles Average Week Get Intercept Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ICPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ENTA News Today MACK News Today ICVX News Today GRCL News Today DNTH News Today WVE News Today COGT News Today STOK News Today CELC News Today CRBP News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ICPT) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intercept Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.